USPTO serial 79437294
MYLIFE DIABETES CARE
Reviewed by CopyMark Law Group
Status 645Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- VAGHANI, MAYUR C
- Law office
- TMO LAW OFFICE 124
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Need help with MYLIFE DIABETES CARE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Joel D. Leviton
Joel D. Leviton Stinson LLP50 South Sixth Street, Suite 2600Minneapolis, MN 55402United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable or recorded software, particularly calculation, analysis, display, reading and control software, for medical, diagnostic, and medicinal purposes for depicting and analyzing data namely blood glucose values, blood glucose trends versus time, blood glucose target value, current bolus values, bolus history, insulin on board or unused insulin, carbohydrate values, carbohydrate factor, insulin sensitivity factor, duration of insulin action, carbohydrate to insulin factor, calculation and display of meal bolus, calculation and display of correction bolus, calculation and display of insulin stacking, display of bolus suggestion, current basal rate, basal rate profile, basal rate history provided by medical instruments and devices for continuous subcutaneous insulin infusion, namely, insulin pumps, blood glucose meters, and patch pumps; downloadable or recorded software for managing data pertaining to infused insulin and infused insulin history of patients using insulin pumps; downloadable or recorded software for data management of patients using insulin pump, all in the field of treating diabetes and diabetes care | ACTIVE | — |
| 010 | Administering apparatus for medical or therapeutic self-medication in particular for treating diabetes, comprising infusion, perfusion and injection apparatus and their accessories in the nature of reservoirs, ampoules, adapted bags, bandages for wearing said apparatus; insulin pumps; needle devices in the nature of inserters and insertion needles for mounting cannulas; needles for use with injection or perfusion devices; infusion and perfusion sets suitable to be connected to injection and perfusion devices for self-medication, in particular for treating diabetes; infusion and perfusion tubes suitable for connecting injection and perfusion devices for self-medication, in particular for treating diabetes with respective infusion and perfusion sets; catheters: ampoules for use with injection and perfusion devices for self-medication, in particular for treating diabetes; accessories therefor in the nature of inserters, mounting aids, adapted pouches and bags for transport and storage; medical measuring and control devices in the nature of insulin pumps and devices for self-medication; diabetes monitoring apparatus in the nature of blood glucose meters, all in the field of treating diabetes and diabetes care | ACTIVE | — |
| 016 | Printed handbooks in the field of self-medication, living with diabetes and handling of devices for self-medication, in particular insulin pumps; printed matter, namely, books, booklets, periodicals, journals and magazines in the field of self-medication, living with diabetes and handling of devices for self-medication, in particular insulin pumps; printed instructional or teaching material in the field of self-medication, living with diabetes and handling of devices for self-medication, in particular insulin pumps; printed club magazines intended for club members in the field of self-medication, living with diabetes and handling of devices for self-medication; printed journals in the field of lifestyles; printed journals in the field of health; printed journals in the field of events for people living with diabetes, for healthcare providers and for friends and relatives of people living with diabetes; printed medical information journals | ACTIVE | — |
| 038 | Provision of access to information for user of medical instruments and devices for self-medication, particularly diabetes therapies, by means of a global computer information network; providing online information forums and chat rooms for conveyance of news and information in between computer users with regard to medical instruments and devices for self-medication, particularly, diabetes therapies and with regard to health, diet, fitness issues or life style among diabetics and their circle | ACTIVE | — |
| 042 | Scientific and technological services, namely, providing temporary use of online, non-downloadable software for use in performing calculation, evaluation, display, reading and control of medical and diagnostic machines and apparatus for medical and diagnostic purposes, all in the field of treating diabetes and diabetes care | ACTIVE | — |
| 044 | Medical services; health care | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by mylife Diabetes Care AG
- Other trademarks owned by TecMed AG
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 016
- Other trademarks in Class 038
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named MYLIFE DIABETES CARE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 13, 2026 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Aug 13, 2026 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 13, 2026 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 20, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 20, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 20, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 20, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 20, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 20, 2026 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jul 20, 2026 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Jul 2, 2026 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Apr 9, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 5, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 22, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 22, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 25, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 19, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 18, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 15, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 25, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 25, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 20, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |